Total Funding
30
52
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
67503
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
- Jason Kralic: Co-founder & CEO
About the Company
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury.
It was founded in 2018 and is based in Hillsborough, North Carolina.
